INDIANAPOLIS, Oct. 27 Eli Lilly and Company(NYSE: LLY) today announced the introduction of a color differentiation systemfor U-100 insulin products marketed in the United States, including vials,pens ...
Humalog (insulin lispro) and Humulin N (insulin isophane human) are brand-name prescription* medications. They’re approved by the Food and Drug Administration (FDA) to help treat type 1 and type 2 ...
DANBURY, CT--(Marketwired - August 11, 2014) - Biodel Inc. (BIOD) announced positive preliminary results from Study 3-152, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated ...
DANBURY, CT--(Marketwired - January 07, 2015) - Biodel Inc. (BIOD) announced positive preliminary results from Study 3-151, a Phase 2a clinical trial comparing Biodel's proprietary, concentrated ...
If you have diabetes, your doctor might suggest Humalog (insulin lispro) as a treatment option for your condition. Along with other questions you may have about the drug, you could be wondering about ...
Lilly announced that 3mL (300-unit) vials of Humalog (insulin lispro [recombinant]) and Humulin R U-100 (regular insulin [human, recombinant]) will be made available to hospitals in January 2010.
Humalog (insulin lispro) is a prescription drug that’s used to help treat diabetes. Humalog comes as a liquid solution for infusion or injection under the skin. Humalog comes in two versions: Humalog ...
Humalog is given as an injection, and there are two types of the drug: Some forms of Humalog and Humalog Mix are available as generics or biosimilars. To learn more, see “Generic or biosimilar ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Do not use if you have ever had an allergic reaction to insulin lispro ...
The new smaller vial - for Lilly's Humalog® (insulin lispro injection [rDNA origin]) and Humulin® R-U100 (regular insulin human injection, USP [rDNA origin)]) - is intended to provide hospitals more ...
Adocia confirms positive clinical results for its BioChaperone(R) Combo, a combination of long-acting insulin glargine and fast-acting insulin lispro BioChaperone Combo is the first combination based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results